EUVIMEDEUVIMED entdecken
Crossref

The progress and perspectives of CAR-T cell therapy

Yan Peng, Zhenqing Feng

Blood&Genomics · 2021

DOI: 10.46701/bg.2021022021126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood&Genomics, 2021. Verfasst von Yan Peng und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CAR-T cell therapy has already achieved world-renowned clinical effects in the treatment of hematological malignancies. Due to the tumor heterogeneity, immunosuppressive microenvironment, and other factors, CAR-T cell therapy has still not shown obvious clinical efficacy in clinical treatment of solid tumors. However, great progress has been made in the preparation of CAR-T cells in recent years, including T cells redirected for universal cytokine mediated killing, universal CAR -T cells, non-viral vector CAR-T cells, SynNotch technology, SUPRA CAR technology, regulated CAR-T cells, and bi-specific CAR-T cells, etc. Future research and development of CAR-T cell therapy will be focused on these following aspects: the combined application of CAR-T cells with different targets, known as "Cocktail CAR-T cells", is expected to increase efficiency toward solid tumors; based on systemic biology/synthetic biology theories, CAR-T cells are likely to be transformed to robot or intelligent system by introducing sensors, logic gates, and logic circuits. This article mainly comments on research progress and perspectives on CAR-T cell therapy in solid tumor treatment.

Zitieren

APA

Peng, Y., & Feng, Z. (2021). The progress and perspectives of CAR-T cell therapy. Blood&Genomics. https://doi.org/10.46701/bg.2021022021126

Vancouver

Peng Y, Feng Z. The progress and perspectives of CAR-T cell therapy. Blood&Genomics. 2021. doi:10.46701/bg.2021022021126

BibTeX
@article{Peng2021,
  author = {Peng, Yan and Feng, Zhenqing},
  title = {The progress and perspectives of CAR-T cell therapy},
  journal = {Blood&Genomics},
  year = {2021},
  doi = {10.46701/bg.2021022021126}
}
Kostenlos starten →